Last updated on August 2019

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)


Brief description of study

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Clinical Study Identifier: NCT03057977

Find a site near you

Start Over

San-Ai Hospital

Saitama, Saitama, Japan
3.34miles
  Connect »

Sekino Hospital

Tokyo, Toshima-ku, Japan
5.82miles
  Connect »

Kosekai Iwatsuki-minami Hospital

Saitama, Saitama, Japan
7.79miles
  Connect »